These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 6165278)
1. Sensitivity of human ovarian carcinoma cells to interferon and other antitumor agents as assessed by an in vitro semi-solid agar technique. Epstein LB; Shen JT; Abele JS; Reese CC Ann N Y Acad Sci; 1980; 350():228-44. PubMed ID: 6165278 [TBL] [Abstract][Full Text] [Related]
2. Review of experience with interferon and drug sensitivity testing of ovarian carcinoma in semisolid agar culture. Epstein LB; Marcus SG Cancer Chemother Pharmacol; 1981; 6(3):273-7. PubMed ID: 6172214 [TBL] [Abstract][Full Text] [Related]
3. Further experience in testing the sensitivity of human ovarian carcinoma cells to interferon in an in vitro semisolid agar culture system: comparison of solid and ascitic forms of the tumor. Epstein LB; Shen JT; Abele JS; Reese CC Prog Clin Biol Res; 1980; 48():277-90. PubMed ID: 6163159 [TBL] [Abstract][Full Text] [Related]
4. Influence of interferon on the growth of primary ovarian carcinoma cells in a semi-solid agar system: comparison with clinical effects of interferon therapy. Ling P; Einhorn S; Anjegård IM; Brenning G; Einhorn N; Strander H Med Oncol Tumor Pharmacother; 1987; 4(2):81-6. PubMed ID: 3669781 [TBL] [Abstract][Full Text] [Related]
5. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome. Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801 [TBL] [Abstract][Full Text] [Related]
6. [Sensitivity of clonogenic cells of human ascitic ovarian cancer to antitumor agents]. Potapov SL; Korman DB; Shamaev VI; Ershova RB; Makarov OV Eksp Onkol; 1987; 9(4):47-50. PubMed ID: 3678125 [TBL] [Abstract][Full Text] [Related]
7. Sensitivity of a neoplastic epithelial duct cell line from a human submandibular salivary gland to human leukocyte interferon as assessed by an in vitro semi-solid agar technique. Sato M; Yoshida H; Yanagawa T; Yura Y; Urata M Int J Oral Surg; 1982 Jun; 11(3):183-9. PubMed ID: 6182119 [TBL] [Abstract][Full Text] [Related]
8. Establishment of Primary Cell Culture From Ascitic Fluid and Solid Tumor Obtained From Epithelial Ovarian Carcinoma Patients. Kar R; Chawla D; Gupta B; Mehndiratta M; Wadhwa N; Agarwal R Int J Gynecol Cancer; 2017 Nov; 27(9):2000-2005. PubMed ID: 28816710 [TBL] [Abstract][Full Text] [Related]
9. [Human tumor clonogenic assay in human breast cancer]. Kobayashi T; Kuraishi Y; Aiba K; Inoue K Gan To Kagaku Ryoho; 1985 Aug; 12(8):1566-72. PubMed ID: 3927846 [TBL] [Abstract][Full Text] [Related]
10. In-vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy. Alberts DS; Samon SE; Chen HS; Surwit EA; Soehnlen B; Young L; Moon TE Lancet; 1980 Aug; 2(8190):340-2. PubMed ID: 6105478 [TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy testing for human ovarian cancer using in vitro colony assay]. Inoue K Gan To Kagaku Ryoho; 1985 Aug; 12(8):1593-8. PubMed ID: 2411225 [TBL] [Abstract][Full Text] [Related]
12. Human ovarian cancer colony formation: growth from malignant washings and pharmacologic applications. Ozols RF; Willson JK; Young RC Prog Clin Biol Res; 1980; 48():247-57. PubMed ID: 7208519 [No Abstract] [Full Text] [Related]
13. Soft agar colony formation assay for in vitro testing of sensitivity to chemotherapy of gynecologic malignancies. Williams TJ; Lieber MM; Podratz KC; Malkasian GD Am J Obstet Gynecol; 1983 Apr; 145(8):940-7. PubMed ID: 6837681 [TBL] [Abstract][Full Text] [Related]
14. Use of in vitro method to predict response of human ovarian carcinoma cells to chemotherapeutic agents. Buckshee K; Roy PK; Chapekar TN Int J Gynaecol Obstet; 1984 Oct; 22(5):371-4. PubMed ID: 6151922 [TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of interferon against murine osteogenic sarcoma in vitro and in vivo. Glasgow LA; Crane JL; Kern ER; Youngner JS Cancer Treat Rep; 1978 Nov; 62(11):1881-8. PubMed ID: 282006 [TBL] [Abstract][Full Text] [Related]
16. Colony-forming ability of human ovarian carcinomas in the Courtenay soft agar assay. Tveit KM; Kaern J; Hoifodt HK; Pettersen EO; Abeler V; Davy M; Hannisdal E; Trope C Anticancer Res; 1989; 9(6):1577-82. PubMed ID: 2483300 [TBL] [Abstract][Full Text] [Related]
17. Patterns of tumor colony development over time in soft-agar culture. Kirkels WJ; Pelgrim OE; Hoogenboom AM; Aalders MW; Debruyne FM; Vooijs GP; Herman CJ Int J Cancer; 1983 Oct; 32(4):399-406. PubMed ID: 6194124 [TBL] [Abstract][Full Text] [Related]
18. [Primary drug resistance/sensitivity in vitro and clininical outcome in ovarian cancer patients]. Sedláková I; Tosner J; Cervinka M; Brigulová K; Rezác A; Spacek J; Laco J; Skapinec P Ceska Gynekol; 2011 Jun; 76(3):184-9. PubMed ID: 21838147 [TBL] [Abstract][Full Text] [Related]
19. Limitations of drug sensitivity testing in soft agar for clinical management of patients with ovarian carcinoma. Arbuck SG; Pavelic ZP; Piver MS; Slocum HK; Malfetano J; Gamarra M; Rustum YM Obstet Gynecol; 1985 Jul; 66(1):115-20. PubMed ID: 3892385 [TBL] [Abstract][Full Text] [Related]
20. Effects of cloned human leukocyte interferons in the human tumor stem cell assay. Salmon SE; Durie BG; Young L; Liu RM; Trown PW; Stebbing N J Clin Oncol; 1983 Mar; 1(3):217-25. PubMed ID: 6686847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]